SPDR S&P Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in SPDR S&P Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7M | 42k | 41.62 |
| 2023-09-30 | $914k | 23k | 39.75 |
| 2023-06-30 | $979k | 24k | 40.99 |
| 2023-03-31 | $1.0M | 25k | 41.01 |
| 2022-12-31 | $21M | 523k | 40.95 |
| 2022-09-30 | $17M | 403k | 42.02 |
| 2022-06-30 | $18M | 436k | 42.00 |
| 2022-03-31 | $1.4M | 31k | 45.28 |
| 2021-12-31 | $1.3M | 29k | 46.17 |
| 2021-09-30 | $1.3M | 28k | 47.43 |
| 2021-06-30 | $1.5M | 29k | 51.76 |
| 2021-03-31 | $1.5M | 30k | 50.35 |
| 2020-12-31 | $1.6M | 30k | 52.07 |
| 2020-09-30 | $1.4M | 31k | 43.48 |
| 2020-06-30 | $1.3M | 29k | 42.98 |
| 2020-03-31 | $1.1M | 29k | 36.09 |
| 2019-12-31 | $1.5M | 32k | 45.67 |
| 2019-09-30 | $1.1M | 31k | 35.59 |
| 2019-06-30 | $1.3M | 34k | 39.82 |
| 2019-03-31 | $1.4M | 34k | 41.57 |
| 2018-12-31 | $1.8M | 50k | 36.63 |
| 2018-09-30 | $6.7M | 138k | 48.58 |
| 2018-06-30 | $3.2M | 73k | 43.01 |
| 2018-03-31 | $3.4M | 80k | 41.88 |
| 2017-12-31 | $5.7M | 132k | 43.50 |
| 2017-09-30 | $6.4M | 150k | 42.55 |
| 2017-06-30 | $11M | 243k | 43.03 |
| 2017-03-31 | $18M | 441k | 41.83 |
| 2016-12-31 | $25M | 634k | 39.09 |
| 2016-09-30 | $19M | 437k | 44.19 |
| 2016-06-30 | $18M | 437k | 41.80 |
| 2016-03-31 | $19M | 465k | 40.24 |
| 2015-12-31 | $28M | 553k | 51.20 |
| 2015-09-30 | $21M | 454k | 46.92 |
| 2015-03-31 | $30M | 244k | 123.52 |